MAINTENANCE OF CLINICAL, ENDOSCOPIC, AND BIOMARKER IMPROVEMENTS WITH UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: A POST HOC ANALYSIS OF THE PHASE 3 U-ENDURE STUDY

Remo Panaccione  ¹     Maria T. Abreu  ²     Raja Atreya  ³     Peter Bossuyt  ⁴     Scott Lee  ⁵     George A. DuVall  ⁶     Edouard Louis  ⁷     Satoshi Tanida  ⁸     Ana Paula Machado De Lacerda  ⁹     Elena Dubcenco     Chirag Doshi     Andrew Garrison     Julian Panés  ^10    
1 Cumming School of Medicine, University of Calgary, Calgary, Canada
² University of Miami Miller School of Medicine, Miami, United States
³ Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
⁴ Imelda General Hospital, Bonheiden, Belgium
⁵ University of Washington Medical Center, Seattle, United States
⁶ Tyler Research Institute, Tyler, United States
⁷ University Hospital CHU of Liège, Liège, Belgium
⁸ Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
⁹ AbbVie Inc., North Chicago, United States
¹⁰ Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain

Topic
Endoscopy, IBD

Session
Hit the road JAK: Part 1

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)